- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03560492
Postural Garment Versus Exercises for Women With Cervical Pain
A Comparative Study of Postural Garment Versus Exercises for Women With Non-specific Cervical Pain: a Randomised Crossover Trial.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
OBJECTIVE: To investigate the effects of a postural garment versus exercises in nurses with non-specific cervical pain.
DESIGN: Randomized cross over clinical trial with a 3 months sequence treatment and a 3 months washout period..
PARTICIPANTS: Nurses and allied health professionals with cervical pain aged 21 to 55 years.
INTERVENTIONS:
Participants are allocated at random to receive interventions in two groups:
- P+ : a postural garment (Posture Plus Force - FGP srl ® - Italy) to be worn from 2 to 4 hours per day, during 90 days.
- Ex: five physiotherapy sessions to learn stretching and strengthening exercises (20 minutes) with instructions to continue at home on a daily basis for 90 days.
The subjects in each group will be cross over after three months of wash out period.
MAIN OUTCOME MEASURES:
The primary outcomes are postural control and pain intensity. Pictures on sagittal and frontal plane as well as measurements of static posturography with a scan (SpinalMouse ®) are conducted at T0 (pre-intervention), T1 immediately after garment fitting for P+ group and after the 5th session for Ex group, T30, T60 and T90 at day 30, day 60 and day 90 of follow-up. Pain is measured by visual analogue scale (VAS) on the same assessment days.
STATISTICAL ANALYSIS:
Statistical analysis is conducted following intention-to-treat principles, and the treatment effects calculated using linear mixed models.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Spanish
-
Escaldes-engordany, Spanish, Andorra, AD700
- Hospital N Sra de Meritxell - Rehabilitation Department
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Nurses and health allied professionals females with cervical pain
- Voluntarily signed informed consent
- Able to wear the garment and to do exercises and follow up assessments
Exclusion Criteria:
- Pregnancy
- Malignancy or other severe disease
- Cervical pain with significant extremity symptoms and/or neurological dysfunction (cervical radiculopathy and cervical spondylotic myelopathy)
- Unable to perform exercises
- Unwilling to do follow up assessments
- Psychiatric disorders
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Posture Plus Force
Participants are provided with the posture garment.
They have to wear it 2 to 4 h per day for a 3 month period.
Participants receive a logbook that should be filled every day.
|
Participants are provided with the appropriate size of a posture garment which includes thoracic and abdominal tensional bands.
They are instructed to wear it 2 to 4 h per day for a 3 month period and record compliance in a logbook daily.
|
ACTIVE_COMPARATOR: Exercise
A physiotherapist teaches exercises to participants (5 sessions of 20 minutes each of stretching and strengthening exercises).
Exercises are focused on cervical and dorsal areas, Participants receive instructions to continue at home on a daily basis for 3 months.
Participants receive a logbook that should be filled every day.
|
5 sessions of exercises of 20 minutes each.
Participants have to do a set of cervical, dorsal and abdominal stretching and strengthening exercises.
Participants receive instructions to continue at home on a daily basis for 3 months and record compliance in a logbook.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline cervical Pain measured with a visual analog scale at 3 months
Time Frame: Pain is assessed pre-intervention (Day 0) and at Month 3 of follow-up.
|
Visual analogue scale is a psychometric measuring instrument designed to document cervical pain severity in individual subjects.
It achieves a rapid (statistically measurable and reproducible) classification of symptom severity.
A 100-mm long horizontal line with verbal descriptors is used to grade the amount of pain that a patient feels from no pain (left 0 mm) to an extreme amount of pain (right 100 mm).
|
Pain is assessed pre-intervention (Day 0) and at Month 3 of follow-up.
|
Change from baseline cervical Pain at 3 months (after the wash out period)
Time Frame: After the washout period, pain is assessed at baseline (Month 6) and after 3 months of intervention (Month 9)
|
Visual analogue scale is a psychometric measuring instrument designed to document cervical pain severity in individual subjects.
It achieves a rapid (statistically measurable and reproducible) classification of symptom severity.
A 100-mm long horizontal line with verbal descriptors is used to grade the amount of pain that a patient feels from no pain (left 0 mm) to an extreme amount of pain (right 100 mm).
|
After the washout period, pain is assessed at baseline (Month 6) and after 3 months of intervention (Month 9)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Posture measured by angle of Kyphosis and angle of lordosis with a computerized device (SpinalMouse® )
Time Frame: Posture is assessed pre-intervention (Day 0))
|
SpinalMouse ® is a device that, combined with a computer program, assesses the curvatures of the spine without applying radiation.
The device is guided manually on the skin along the spinous process apophysis from C7 to S3.
The measuring head follows their contour in the sagittal plane and records clinically relevant data.
A software program using an algorithm uses this information to calculate the angle of kyphosis and angle of lordosis.
Data obtained have been proved to be reliable and accurate
|
Posture is assessed pre-intervention (Day 0))
|
Posture measured by angle of Kyphosis and angle of lordosis with a computerized device (SpinalMouse® )
Time Frame: Posture is assessed at Month 3 of follow-up.
|
SpinalMouse ® is a device that, combined with a computer program, assesses the curvatures of the spine without applying radiation.
The device is guided manually on the skin along the spinous process apophysis from C7 to S3.
The measuring head follows their contour in the sagittal plane and records clinically relevant data.
A software program using an algorithm uses this information to calculate the angle of kyphosis and angle of lordosis.
Data obtained have been proved to be reliable and accurate
|
Posture is assessed at Month 3 of follow-up.
|
Posture measured by angle of Kyphosis and angle of lordosis with a computerized device (SpinalMouse® )
Time Frame: Posture measurement is repeated after the 3-month washout period (Month 6)
|
SpinalMouse ® is a device that, combined with a computer program, assesses the curvatures of the spine without applying radiation.
The device is guided manually on the skin along the spinous process apophysis from C7 to S3.
The measuring head follows their contour in the sagittal plane and records clinically relevant data.
A software program using an algorithm uses this information to calculate the angle of kyphosis and angle of lordosis.
Data obtained have been proved to be reliable and accurate
|
Posture measurement is repeated after the 3-month washout period (Month 6)
|
Posture measured by angle of Kyphosis and angle of lordosis with a computerized device (SpinalMouse® )
Time Frame: Posture is assessed at Month 9 (end of study) after the washout period and the cross over 3 months intervention
|
SpinalMouse ® is a device that, combined with a computer program, assesses the curvatures of the spine without applying radiation.
The device is guided manually on the skin along the spinous process apophysis from C7 to S3.
The measuring head follows their contour in the sagittal plane and records clinically relevant data.
A software program using an algorithm uses this information to calculate the angle of kyphosis and angle of lordosis.
Data obtained have been proved to be reliable and accurate
|
Posture is assessed at Month 9 (end of study) after the washout period and the cross over 3 months intervention
|
Neck Disability Index
Time Frame: Neck disability is assessed pre-intervention (Day 0)
|
Cervical pain-related disability will be assessed with the validated Spanish version of Neck Disability Index.
The Neck Disability Index is a ten-item questionnaire based on the Oswestry Low Back Pain Index that assesses disability associated with neck pain and whiplash.
There are four items that relate to subjective symptomatology (pain intensity, headache, concentration, sleeping) and six items that relate to activities of daily living (lifting, work, driving, recreation, personal care, reading).
The questionnaire is self and administered requires only 5-10 minutes to complete.
It is scored from 0 (no disability) to 50 (maximum disability).
Each subject select from one of six potential responses for each item ranging from no disability (0) to total disability (5).
The ten items are summed to gain the total score.
|
Neck disability is assessed pre-intervention (Day 0)
|
Neck Disability Index
Time Frame: Neck disability is assessed at Month 3 of follow-up.
|
Cervical pain-related disability will be assessed with the validated Spanish version of Neck Disability Index.
The Neck Disability Index is a ten-item questionnaire based on the Oswestry Low Back Pain Index that assesses disability associated with neck pain and whiplash.
There are four items that relate to subjective symptomatology (pain intensity, headache, concentration, sleeping) and six items that relate to activities of daily living (lifting, work, driving, recreation, personal care, reading).
The questionnaire is self and administered requires only 5-10 minutes to complete.
It is scored from 0 (no disability) to 50 (maximum disability).
Each subject select from one of six potential responses for each item ranging from no disability (0) to total disability (5).
The ten items are summed to gain the total score.
|
Neck disability is assessed at Month 3 of follow-up.
|
Neck Disability Index
Time Frame: Neck disability is repeated after the 3-month washout period (Month 6)
|
Cervical pain-related disability will be assessed with the validated Spanish version of Neck Disability Index.
The Neck Disability Index is a ten-item questionnaire based on the Oswestry Low Back Pain Index that assesses disability associated with neck pain and whiplash.
There are four items that relate to subjective symptomatology (pain intensity, headache, concentration, sleeping) and six items that relate to activities of daily living (lifting, work, driving, recreation, personal care, reading).
The questionnaire is self and administered requires only 5-10 minutes to complete.
It is scored from 0 (no disability) to 50 (maximum disability).
Each subject select from one of six potential responses for each item ranging from no disability (0) to total disability (5).
The ten items are summed to gain the total score.
|
Neck disability is repeated after the 3-month washout period (Month 6)
|
Neck Disability Index
Time Frame: Neck disability is assessed at Month 9 (end of study) after the washout period and the cross over 3 months intervention
|
Cervical pain-related disability will be assessed with the validated Spanish version of Neck Disability Index.
The Neck Disability Index is a ten-item questionnaire based on the Oswestry Low Back Pain Index that assesses disability associated with neck pain and whiplash.
There are four items that relate to subjective symptomatology (pain intensity, headache, concentration, sleeping) and six items that relate to activities of daily living (lifting, work, driving, recreation, personal care, reading).
The questionnaire is self and administered requires only 5-10 minutes to complete.
It is scored from 0 (no disability) to 50 (maximum disability).
Each subject select from one of six potential responses for each item ranging from no disability (0) to total disability (5).
The ten items are summed to gain the total score.
|
Neck disability is assessed at Month 9 (end of study) after the washout period and the cross over 3 months intervention
|
Pain Catastrophizing Scale
Time Frame: Assessed pre-intervention (Day 0)
|
In order to assess the catastrophizing dimension related to pain, the Pain Catastrophizing Scale is used.
It is a 13-item scale, with each item rated on a 5-point scale: 0 (Not at all) to 4 (all the time) that yields a total score and three subscale scores assessing rumination, magnification and helplessness.
Total score ranges from 0 to 52.
It is a self-report measurement tool that provided a valid index of catastrophizing in clinical populations.
|
Assessed pre-intervention (Day 0)
|
Pain Catastrophizing Scale
Time Frame: Assessed at Month 3 of follow-up.
|
In order to assess the catastrophizing dimension related to pain, the Pain Catastrophizing Scale is used.
It is a 13-item scale, with each item rated on a 5-point scale: 0 (Not at all) to 4 (all the time) that yields a total score and three subscale scores assessing rumination, magnification and helplessness.
Total score ranges from 0 to 52.
It is a self-report measurement tool that provided a valid index of catastrophizing in clinical populations.
|
Assessed at Month 3 of follow-up.
|
Pain Catastrophizing Scale
Time Frame: Pain Catastrophizing scale is repeated after the 3-month washout period (Month 6)
|
In order to assess the catastrophizing dimension related to pain, the Pain Catastrophizing Scale is used.
It is a 13-item scale, with each item rated on a 5-point scale: 0 (Not at all) to 4 (all the time) that yields a total score and three subscale scores assessing rumination, magnification and helplessness.
Total score ranges from 0 to 52.
It is a self-report measurement tool that provided a valid index of catastrophizing in clinical populations.
|
Pain Catastrophizing scale is repeated after the 3-month washout period (Month 6)
|
Pain Catastrophizing Scale
Time Frame: Catastrophizing is assessed at Month 9 (end of study) after the washout period and the cross over 3 months intervention
|
In order to assess the catastrophizing dimension related to pain, the Pain Catastrophizing Scale is used.
It is a 13-item scale, with each item rated on a 5-point scale: 0 (Not at all) to 4 (all the time) that yields a total score and three subscale scores assessing rumination, magnification and helplessness.
Total score ranges from 0 to 52.
It is a self-report measurement tool that provided a valid index of catastrophizing in clinical populations.
|
Catastrophizing is assessed at Month 9 (end of study) after the washout period and the cross over 3 months intervention
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Garment comfort
Time Frame: garment comfort is assessed at Month 1 when allocated to the garment group intervention.
|
Garment comfort is evaluated with a 5-point Likert scale with the following anchors • 1 - Very dissatisfied • 2 - dissatisfied • 3 - unsure • 4 - satisfied • 5 - Very satisfied
|
garment comfort is assessed at Month 1 when allocated to the garment group intervention.
|
Garment comfort
Time Frame: garment comfort is assessed at Month 3 when allocated to the garment group intervention.
|
Garment comfort is evaluated with a 5-point Likert scale with the following anchors • 1 - Very dissatisfied • 2 - dissatisfied • 3 - unsure • 4 - satisfied • 5 - Very satisfied
|
garment comfort is assessed at Month 3 when allocated to the garment group intervention.
|
Assessment of global perceived effect of treatment
Time Frame: Perceived effect of treatment is assessed at Month 3 of follow-up.
|
Assessment of global perceived effect of treatment is performed with a Visual Analog Scale .
Visual analogue scale is a psychometric measuring instrument designed to document perceived effect of the treatment in individual subjects.
A 100-mm long horizontal line with verbal descriptors is used to grade the perceived effect that a patient feels from no improvement (left 0 mm) to an great improvement (right 100 mm).
|
Perceived effect of treatment is assessed at Month 3 of follow-up.
|
Assessment of global perceived effect of treatment
Time Frame: Perceived effect of treatment is assessed at Month 9 (end of study)
|
Assessment of global perceived effect of treatment is performed with a Visual Analog Scale .
Visual analogue scale is a psychometric measuring instrument designed to document perceived effect of the treatment in individual subjects.
A 100-mm long horizontal line with verbal descriptors is used to grade the perceived effect that a patient feels from no improvement (left 0 mm) to an great improvement (right 100 mm).
|
Perceived effect of treatment is assessed at Month 9 (end of study)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Merce Avellanet, MD, PhD, Universitat d'Andorra
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UA001GRCSSS
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cervical Pain
-
University of DeustoUniversity of the Basque Country (UPV/EHU); Osakidetza; Matia FoundationRecruitingCervical Pain | Cervical Radiculopathy | Cervical Radicular PainSpain
-
Afyonkarahisar Health Sciences UniversityCompletedMusculoskeletal Diseases | Cervical Pain | Radiculopathy | Cervical Disc Disease | Cervical Radicular PainTurkey
-
Palo Alto Veterans Institute for ResearchAllerganCompletedSubacute Cervical Pain | Subacute Upper Back Pain
-
Ahram Canadian UniversityRecruiting
-
Hacettepe UniversityRecruitingNeck Pain | Cervical Pain | Neck Pain, Posterior | Neck Muscle Issue | Cervical Pain, PosteriorTurkey
-
University of UtahRecruitingCervical Pain | Cervical Facet Joint PainUnited States
-
Fayoum University HospitalCompletedInjection | Intervention | Epidural | CervicalEgypt
-
Jaseng Hospital of Korean MedicineCompletedLumbar and Cervical PainKorea, Republic of
-
Region SkaneUnknownNeck Pain | Cervical Disc Disease | Radiculopathy, Cervical | Cervical Foraminal Stenosis
-
Istanbul Medipol University HospitalCompletedPain | Cervical Radiculopathy | Cervical Disc Disease | Cervical Disc Herniation | Cervical Radicular Pain | Cervical; HerniaTurkey
Clinical Trials on Posture garment
-
Loma Linda UniversityWithdrawnRotator Cuff TendinopathyUnited States
-
University Hospital Schleswig-HolsteinCompleted
-
The University of Texas Medical Branch, GalvestonU.S. Department of EducationWithdrawn
-
University of ManitobaHealth Sciences Centre Foundation, ManitobaWithdrawn
-
Chinese University of Hong KongThe Hong Kong Polytechnic UniversityCompletedKnee Arthropathy | Hypertrophic Scar | Hip ArthropathyHong Kong
-
University of Colorado, DenverNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Recruiting
-
Centre Hospitalier Universitaire, AmiensCompletedProblem Behavior | Dementia | Elderly | Adapted Garment Prototype | Sphincter DisordersFrance
-
Hacettepe UniversityNot yet recruitingRespiratory Function Test | Balanced; Rearrangement
-
University of Wisconsin, MadisonActive, not recruitingCentral Venous CathetersUnited States
-
Hôpital Raymond PoincaréUnknownHypermobility Type Ehlers-Danlos SyndromeFrance